These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23785218)

  • 1. Characterization of the Bas-Congo virus glycoprotein and its function in pseudotyped viruses.
    Steffen I; Liss NM; Schneider BS; Fair JN; Chiu CY; Simmons G
    J Virol; 2013 Sep; 87(17):9558-68. PubMed ID: 23785218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel rhabdovirus associated with acute hemorrhagic fever in central Africa.
    Grard G; Fair JN; Lee D; Slikas E; Steffen I; Muyembe JJ; Sittler T; Veeraraghavan N; Ruby JG; Wang C; Makuwa M; Mulembakani P; Tesh RB; Mazet J; Rimoin AW; Taylor T; Schneider BS; Simmons G; Delwart E; Wolfe ND; Chiu CY; Leroy EM
    PLoS Pathog; 2012 Sep; 8(9):e1002924. PubMed ID: 23028323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular aspects of rhabdovirus entry.
    Albertini AA; Baquero E; Ferlin A; Gaudin Y
    Viruses; 2012 Jan; 4(1):117-39. PubMed ID: 22355455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human tibrovirus envelope glycoproteins.
    Munyeku-Bazitama Y; Saito T; Hattori T; Miyamoto H; Lombe BP; Mori-Kajihara A; Kajihara M; Muyembe-Tamfum J-J; Igarashi M; Park E-s; Morikawa S; Makiala-Mandanda S; Takada A
    J Virol; 2024 Jul; 98(7):e0049924. PubMed ID: 38953631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry.
    Caì Y; Yú S; Jangra RK; Postnikova EN; Wada J; Tesh RB; Whelan SPJ; Lauck M; Wiley MR; Finch CL; Radoshitzky SR; O'Connor DH; Palacios G; Chandran K; Chiu CY; Kuhn JH
    Front Microbiol; 2019; 10():856. PubMed ID: 31105663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced arbovirus surveillance with deep sequencing: Identification of novel rhabdoviruses and bunyaviruses in Australian mosquitoes.
    Coffey LL; Page BL; Greninger AL; Herring BL; Russell RC; Doggett SL; Haniotis J; Wang C; Deng X; Delwart EL
    Virology; 2014 Jan; 448():146-58. PubMed ID: 24314645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion.
    Jeetendra E; Robison CS; Albritton LM; Whitt MA
    J Virol; 2002 Dec; 76(23):12300-11. PubMed ID: 12414970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant vesicular stomatitis virus bearing a lethal mutation in the glycoprotein gene uncovers a second site suppressor that restores fusion.
    Stanifer ML; Cureton DK; Whelan SP
    J Virol; 2011 Aug; 85(16):8105-15. PubMed ID: 21680501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
    Hanika A; Larisch B; Steinmann E; Schwegmann-Weßels C; Herrler G; Zimmer G
    J Gen Virol; 2005 May; 86(Pt 5):1455-1465. PubMed ID: 15831958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity.
    Jeetendra E; Ghosh K; Odell D; Li J; Ghosh HP; Whitt MA
    J Virol; 2003 Dec; 77(23):12807-18. PubMed ID: 14610202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.
    Basu A; Beyene A; Meyer K; Ray R
    J Virol; 2004 May; 78(9):4478-86. PubMed ID: 15078928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entry of rhabdoviruses into animal cells.
    Regan AD; Whittaker GR
    Adv Exp Med Biol; 2013; 790():167-77. PubMed ID: 23884591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pH-sensitive molecular switches that trigger the structural transition of vesicular stomatitis virus glycoprotein from the postfusion state toward the prefusion state.
    Ferlin A; Raux H; Baquero E; Lepault J; Gaudin Y
    J Virol; 2014 Nov; 88(22):13396-409. PubMed ID: 25210175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Bas-Congo virus in Mangala, Democratic Republic of the Congo: a population-based cross-sectional study.
    Munyeku-Bazitama Y; Okitale-Talunda P; Hattori T; Saito T; Lombe BP; Miyamoto H; Mori-Kajihara A; Kajihara M; Nkoy AB; Twabela AT; Masumu J; Ahuka-Mundeke S; Muyembe-Tamfum JJ; Igarashi M; Park ES; Morikawa S; Makiala-Mandanda S; Takada A
    Lancet Microbe; 2024 Jun; 5(6):e529-e537. PubMed ID: 38555924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line.
    Boso G; Somia NV
    PLoS One; 2015; 10(3):e0121455. PubMed ID: 25811758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.
    Whitt MA
    J Virol Methods; 2010 Nov; 169(2):365-74. PubMed ID: 20709108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
    Yonezawa A; Cavrois M; Greene WC
    J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
    Yu D; Wang W; Yoder A; Spear M; Wu Y
    PLoS Pathog; 2009 Oct; 5(10):e1000633. PubMed ID: 19851458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Backbone chemical shift assignments and secondary structure analysis of the U1 protein from the Bas-Congo virus.
    Buchko GW; Clifton MC; Wallace EG; Atkins KA; Myler PJ
    Biomol NMR Assign; 2017 Apr; 11(1):51-56. PubMed ID: 27981424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.